Headlines
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
Published by Global Banking and Finance Review
Posted on March 5, 2025
1 min readLast updated: January 25, 2026
Global Banking and Finance Review
Company
Published by Global Banking and Finance Review
Posted on March 5, 2025
1 min readLast updated: January 25, 2026
A German court ruled that Pfizer and BioNTech infringed on Moderna's COVID-19 vaccine patent, requiring them to disclose earnings and compensate Moderna.
FRANKFURT (Reuters) - A German court in Duesseldorf on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna.
In a statement, the court said that Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that they owe Moderna appropriate compensation, though the ruling can still be appealed to a higher court.
(Reporting by Ludwig Burger, editing by Thomas Escritt)
The German court in Duesseldorf ruled that Pfizer and BioNTech violated a COVID-19 vaccine patent held by Moderna.
Pfizer and BioNTech must provide information on earnings derived from the use of the patent and owe Moderna appropriate compensation.
The article was reported by Ludwig Burger and edited by Thomas Escritt.
Explore more articles in the Headlines category
